Repository corticotropin injection in patients with rheumatoid arthritis resistant to biologic therapies
Peter A Fischer,1 Ronald J Rapoport2 1Sturdy Memorial Hospital, Attleboro, MA, USA; 2Division of Rheumatology, Southcoast Health, Fall River, MA, USA Introduction: Although synthetic and biologic disease-modifying antirheumatic drugs are available, many patients with rheumatoid arthritis have a diff...
Guardado en:
Autores principales: | Fischer PA, Rapoport RJ |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://doaj.org/article/8356bffd7b4141b59310bf5a2dad5e66 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Repository corticotropin injection as adjunctive therapy in patients with rheumatoid arthritis who have failed previous therapies with at least three different modes of action
por: Gillis T, et al.
Publicado: (2017) -
Real-World Treatment Patterns and Outcomes from an Electronic Medical Records Database for Patients with Rheumatoid Arthritis Treated with Repository Corticotropin Injection
por: Hayes K, et al.
Publicado: (2021) -
Achieving comprehensive remission or low disease activity in rheumatoid patients and its impact on workability – Saudi Rheumatoid Arthritis Registry
por: Almoallim H, et al.
Publicado: (2019) -
Evaluation of C-Reactive Protein and Associated Factors Among Patients Suffering from Rheumatoid Arthritis at Tikur Anbessa Specialized Hospital, Addis Ababa, Ethiopia
por: Dessie G, et al.
Publicado: (2021) -
Clinical and serological characteristics of Ecuadorian patients with rheumatoid arthritis
por: Ríos C, et al.
Publicado: (2017)